<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32-pharmaceutics-13-00387">
 <label>32.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>European Medicines Agency (EMA), Committee for Human Medicinal Products (CHMP)</collab>
  </person-group>
  <article-title>Questions and Answers on Ethanol in the Context of the Revision of the Guideline on ‘Excipients in the Label and Package Leaflet of Medical Products for Human Use’ (CPMP/463/00)</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-ethanol-context-revision-guideline-excipients-label-package-leaflet-medicinal_en.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-ethanol-context-revision-guideline-excipients-label-package-leaflet-medicinal_en.pdf</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-03-10">(accessed on 10 March 2020)</date-in-citation>
 </element-citation>
</ref>
